Portola Pharmaceuticals Total Revenue

Portola Pharmaceuticals (PTLA) currently reports a total revenue of $120M as of March 2020. That compares with $56M in the prior-year period — up 117.2% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Portola Pharmaceuticals's total revenue history and peer comparisons.

Portola Pharmaceuticals's total revenue increased from $56M to $120M — a 117.2% year-over-year increase (period ending March 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Portola Pharmaceuticals's total revenue of $120M is lower than the Healthcare sector average of $110B. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Portola Pharmaceuticals reported $120M in total revenue as of March 2020. That compares with $56M in the prior-year period — up 117.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Portola Pharmaceuticals, and consider following PTLA for alerts when major investors trade the stock.